Does the current climax of economy spells nothing but downhill for Biomedical Science (BMS) industry?
Hopes can be set high with key announcements made by leading pharmaceutical companies in Feburary 2009:

Abbott opened its largest nutrition manufacturing facility and announced its extension into nutrition R&D in Singapore;
Schering-Plough opened its Translation Medicine Research Centre;
Lilly announced its collaboration [...]

Within a short span of 2 years, 4 major biomedical companies announced their commercial-scale biologics manufacturing investments in Singapore. These investments include, GlaxoSmithKline’s Biologics’ vaccine plant, Lonza’s two mammalian cell culture facilities, Novartis cell culture plant and Genentech microbial facility.
So what made these companies come to Singapore?
Firstly, it was due to the country’s heavy investments [...]